|
ERO1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.908390E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.510000E-01 |
| Normal-vs-Stage2 |
2.297400E-01 |
| Normal-vs-Stage3 |
1.301170E-01 |
| Normal-vs-Stage4 |
1.382630E-01 |
| Stage1-vs-Stage2 |
4.364100E-02 |
| Stage1-vs-Stage3 |
4.631400E-01 |
| Stage1-vs-Stage4 |
4.069600E-01 |
| Stage2-vs-Stage3 |
3.312400E-02 |
| Stage2-vs-Stage4 |
2.585800E-02 |
| Stage3-vs-Stage4 |
8.671400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.255800E-02 |
| Normal-vs-AfricanAmerican |
7.456100E-02 |
| Normal-vs-Asian |
9.786200E-01 |
| Caucasian-vs-AfricanAmerican |
3.995800E-01 |
| Caucasian-vs-Asian |
2.214200E-01 |
| AfricanAmerican-vs-Asian |
8.299900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.981600E-01 |
| Normal-vs-Female |
8.834400E-02 |
| Male-vs-Female |
9.910200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.699800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.512800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.365000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.682800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.516030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.778800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.841400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.374000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.429800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.012600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.875900E-02 |
| Classical-VS-Follicular |
3.48569999530923E-08 |
| Classical-VS-Other |
4.979800E-02 |
| Classical-VS-Normal |
1.183880E-02 |
| Tall-VS-Follicular |
4.24260000000398E-05 |
| Tall-VS-Other |
1.753900E-02 |
| Tall-VS-Normal |
6.758000E-03 |
| Follicular-VS-Other |
8.400800E-01 |
| Follicular-VS-Normal |
4.382600E-03 |
| Other-VS-Normal |
8.550200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.223800E-01 |
| Normal-vs-N1 |
4.430200E-01 |
| N0-vs-N1 |
2.185200E-01 |
|
|
